A little help from steroids in oncology.

J Transl Int Med

Supportive and Palliative Care Unit, Institut Jules Bordet-Université Libre de Bruxelles, 1000 Brussels, Belgium.

Published: April 2016

Steroids are widely used in oncology and have been demonstrated to possess an anticancer effect or antiswelling effect. They are considered to improve refractory symptoms such as dyspnea or gastrointestinal (GI) obstruction. However, their roles in nonspecific indications are not well proved. Clinical practice and several studies suggest that corticosteroids may be effective in the treatment of bone and neuropathic pain, when administered along with opioids and with other adjuvant analgesics. The decrease in pain intensity is probably connected with both anti-inflammatory and antiswelling effects as well as modulation of neuroimmune interactions and an inhibition of angiogenesis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290916PMC
http://dx.doi.org/10.1515/jtim-2016-0011DOI Listing

Publication Analysis

Top Keywords

steroids oncology
8
help steroids
4
oncology steroids
4
oncology demonstrated
4
demonstrated possess
4
possess anticancer
4
anticancer antiswelling
4
antiswelling considered
4
considered improve
4
improve refractory
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!